Noninvasive, Drug Augmented, Ultra Low Intensity Transcranial Light Photodynamic Treatment of Glioblastoma: LIT-PDT
Preprint
- 25 July 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
This paper presents the rationale for using ultra low intensity transcranial light photodynamic treatment (LIT-PDT) for treating glioblastoma. Glioblastoma is currently treated with maximal safe resection, temozolomide and ionizing irradiation. Mortality in 2024 remains at over 80% within several years from diagnosis. 5-aminolevulinic acid (5-ALA) is a heme precursor that is selectively taken up preferentially by malignant cells, including glioblastoma. Photon energy can be transduced to molecular oxygen by a 5-ALA metabolite, PpIX, transforming oxygen to the singlet state, a reactive oxygen species (ROS) that destroys or damages vital glioblastoma cell structures. In PDT, light energy ~ 100 to 200 J / cm2, at 630 nm is delivered intraoperatively after resection and preoperative oral 5-ALA. This generates ROS cytotoxicity in residual glioblastoma cells within the resection cavity wall. 630 nm light poorly penetrates skin, skull, and brain tissue. That currently restricts PDT to a single intraoperative session using high flux light. LIT-PDT addresses some current shortcomings of 5-ALA PDT treatment. Part 1 analyzes published data indicating that continuous ultra low light flux, 17 μW / cm2, over 24 hours for a total delivery of 1.5 J / cm2, is effective for 5-ALA PDT treatment. That opens the way for repetitive, extracranial light to deliver enough energy for low flux, long duration PDT to any deep brain structure using less than 12 W total distributed over the entire scalp area. In Part 2, by analysis of 5-ALA and PpIX physiology, it became apparent that four non oncology drugs - ciprofloxacin, deferiprone, telmisartan and ziprasidone, will increase energy capture by GB cells, thereby increasing PDT treatment cytotoxicity. A phased pilot study of LIT-PDT treatment is being planned.Keywords
All Related Versions
This publication has 134 references indexed in Scilit:
- Dose response of transcranial near infrared light stimulation on brain functional connectivity and cognition in older adults—A randomized comparisonJournal of Biophotonics, 2023
- Brain photobiomodulation therapy on neurological and psychological diseasesJournal of Biophotonics, 2023
- Understanding the glioblastoma tumor biology to optimize photodynamic therapy: From molecular to cellular eventsJournal of Neuroscience Research, 2020
- Towards anticancer fluoroquinolones: A review articleArchiv der Pharmazie, 2019
- Transcranial Near-Infrared Laser Therapy for Stroke: How to Recover from Futility in the NEST-3 Clinical Trial2016
- Quantitative analysis of transcranial and intraparenchymal light penetration in human cadaver brain tissueLasers in Surgery and Medicine, 2015
- Using the molecular classification of glioblastoma to inform personalized treatmentThe Journal of Pathology, 2013
- Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood–brain barrierBiopharmaceutics & Drug Disposition, 2012
- Interaction of angiotensin receptor type 1 blockers with ATP‐binding cassette transportersBiopharmaceutics & Drug Disposition, 2010
- The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroidsLasers in Surgery and Medicine, 2009